<DOC>
	<DOCNO>NCT00608205</DOCNO>
	<brief_summary>RATIONALE : Radiation therapy use high energy x-ray kill tumor cell . Drugs use chemotherapy , cisplatin fluorouracil , work different way stop growth tumor cell , either kill cell stop divide . Giving radiation therapy together cisplatin fluorouracil may kill tumor cell . It yet know whether radiation therapy cisplatin effective without fluorouracil treat patient head neck cancer . PURPOSE : This randomized phase III trial study radiation therapy cisplatin compare well work without fluorouracil treat patient stage III stage IV head neck cancer .</brief_summary>
	<brief_title>Radiation Therapy Cisplatin With Without Fluorouracil Patients With Stage III Stage IV Head Neck Cancer</brief_title>
	<detailed_description>OBJECTIVES : - To compare relapse-free survival patient treat radiotherapy cisplatin v without fluorouracil . - To compare overall survival , local control without surgery , pattern failure patient treat regimen . - To compare acute long-term toxicity regimens patient . - To compare quality life patient treat regimen . - To prospectively collect biopsy material , mucosal scraping , serum effort generate hypotheses future correlative study . OUTLINE : This multicenter study . Patients stratify accord radiotherapy schedule ( daily v twice daily ) radiotherapy planning ( 2D vs 3D vs intensity-modulated radiotherapy ) . Patients randomize 1 2 treatment arm . - Arm I : Patients undergo full-dose radiotherapy twice daily 5 day week 7 week receive cisplatin IV 1 hour day 1 , 22 , 43 radiotherapy . - Arm II : Patients undergo radiotherapy arm I receive fluorouracil IV cisplatin IV continuously day 1-4 22-25 radiotherapy . Patients biopsy-verified residual disease primary site local recurrence achieve complete response chemoradiotherapy may undergo salvage surgery 12 week completion chemoradiotherapy . Patients complete questionnaire periodically assess late toxicity quality life . After completion study treatment , patient follow periodically .</detailed_description>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm squamous cell carcinoma oral cavity , oropharynx , larynx , hypopharynx No histologic diagnosis squamous cell carcinoma A primary site must identify Must locoregionally confine stage III ( exclude T12 , N1 ) stage IV disease No evidence nodal disease clavicle distant hematogenous metastasis ( M0 ) No stage IVC disease ( stage IVB disease allow ) Deemed appropriate definitive nonoperative management curative intent Resectable disease require No primary cancer nasopharynx , paranasal sinus , salivary gland PATIENT CHARACTERISTICS : ECOG performance status 01 WBC &gt; 3,500/mm³ Platelet count &gt; 100,000/mm³ Serum creatinine &lt; 2.0 mg/dL Alkaline phosphatase &lt; 2 time normal AST &lt; 2 time normal Bilirubin ≤ 2.0 mg/dL Serum calcium normal Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception No unstable uncontrolled angina No clinically apparent jaundice No active infection No history malignancy ( except squamous cell basal cell skin cancer cervical carcinoma situ ) , unless patient continuously diseasefree least 5 year Not poor compliance risk Able withstand rigor intensive treatment Available compliant adequate longterm followup PRIOR CONCURRENT THERAPY : No prior definitive surgery radiotherapy malignancy No prior chemotherapy , immunotherapy , epidermal growth factor receptor inhibitor disease Patients previous definitive surgery , radiation therapy malignancy , patient previous chemotherapy , immunotherapy , EGF receptor inhibition disease ineligible . Exclusion Criteria Patients primary cancer nasopharynx , paranasal sinus salivary gland ineligible . Patients unstable uncontrolled angina , clinically apparent jaundice , active infection ineligible . Patients history malignancy ( except squamous basal cell skin cancer cervical carcinoma insitu ) ineligible , unless patient continuously diseasefree least 5 year . Patients histologic diagnosis squamous cell carcinoma ineligible . Patients might poorcompliance risk ineligible . Pregnant breastfeed woman ineligible . Women/men reproductive potential must willing practice acceptable method birth control prevent pregnancy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>stage III squamous cell carcinoma hypopharynx</keyword>
	<keyword>stage III squamous cell carcinoma lip oral cavity</keyword>
	<keyword>stage III squamous cell carcinoma oropharynx</keyword>
	<keyword>stage III squamous cell carcinoma larynx</keyword>
	<keyword>stage IV squamous cell carcinoma hypopharynx</keyword>
	<keyword>stage IV squamous cell carcinoma lip oral cavity</keyword>
	<keyword>stage IV squamous cell carcinoma oropharynx</keyword>
	<keyword>stage IV squamous cell carcinoma larynx</keyword>
</DOC>